Biotin-DD-XLink-mab

Biotin-DD-XLink-mab

Catalog Number:
A001055401ZED
Mfr. No.:
A079
Price:
$827
  • Size:
    50 µg
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          After proteolytic activation by thrombin, FXIIIa modifies the soft fibrin clot and thereby introducing covalent bonds. First, cross-linking between abutting γ-chains of fibrin is catalyzed and subsequently α2-antiplasmin is incorporated to further increase the resistance against fibrinolysis. Plasmin catalyses the retarded clot dissolution and the release of crosslinked fibrin degradation products (xFDPs / D-dimer). Monoclonal “D-dimer” antibodies (e.g. DD-3B6/22) are commercially available and are used in In Vitro Diagnostics (IVD) to exclude thromboembolic events. However, these monoclonals do not detect the crosslink itself but address a portion of polypeptides within the D-domain after plasmin degradation that are conformationally reactive. Zedira scientists developed a monoclonal antibody which directly recognizes the crosslinked fibrin neoepitope (DD-XLink-mab).For more information klick here: Poster presentation at GRC, 2016 (Girona, Spain)

      • Properties
        • Antibody Type
          monoclonal
          Conjugate
          Biotin
          Formulation
          liquid
          Storage
          Store at < -20 °C
          Note
          INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.
          Antigen
          D-dimers

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.